Scarica l'app Stockscreener
0.6625
1.87%
-0.0126
Dopo l'orario di chiusura:
.66
-0.0025
-0.38%
Calcimedica Inc Borsa (CALC) Ultime notizie
Woodline Partners discloses 8.1% CalciMedica (CALC) stake and sole voting power - Stock Titan
Armistice Capital (CALC) discloses 3.41M-share, 9.99% holding in CalciMedica - Stock Titan
CalciMedica shares see H.C. Wainwright neutral rating reiterated - Investing.com
Price to book forward of CalciMedica, Inc. – NASDAQ:CALC - TradingView
Price to book forward of CalciMedica, Inc. – BOATS:CALC - tradingview.com
Price to sales forward of CalciMedica, Inc. – NASDAQ:CALC - tradingview.com
Price to sales forward of CalciMedica, Inc. – BOATS:CALC - TradingView
CalciMedica Inc (CALC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form 8K CalciMedica Inc For: 11 August By Investing.com - Investing.com UK
CalciMedica, Inc. 2Q 2026: Net loss $7.7M, EPS $(0.45) — 10-Q Summary - TradingView
CalciMedica (CALC) cuts expenses, raises $15M but flags going concern risk - Stock Titan
CalciMedica Releases Q2 2026 Financial Results - news.alphastreet.com
CalciMedica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CalciMedica stock gains 6% as pulmonary hypertension progress offsets Q2 earnings miss - Yahoo Finance
CalciMedica Secures Up To $49 Million Private Placement To Advance Pulmonary Hypertension Pipeline - Minichart
CalciMedica Inc reports results for the quarter ended June 30Earnings Summary - TradingView
CalciMedica Q2 FY26 net loss widens to $7.65 million - Bitget
CalciMedica stock gains 6% despite earnings miss on pulmonary trial By Investing.com - Investing.com South Africa
CalciMedica stock gains 6% despite earnings miss on pulmonary trial - Investing.com
CalciMedica reports Q2 2026 results: $18.6M cash, net loss $7.7M; financing to fund PH programs - TradingView
CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates - Moomoo
CalciMedica Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
CalciMedica, Inc. SEC Filing (Aug 3, 2026) - Stock Titan
CalciMedica Inc (CALC:UR): Stock Price, Quote and News - bnnbloomberg.ca
CalciMedica aligns with FDA on acute pancreatitis trial design By Investing.com - Investing.com Canada
CalciMedica aligns with FDA on acute pancreatitis trial design - Investing.com
CalciMedica Inc (CALC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CalciMedica Inc (CALC) Institutional Confidence - TradingKey
CALC|CalciMedica Inc|Price:0.760|Chg%:+0.044 - TradingKey
CalciMedica Inc (CALC) Cash Flow - TradingKey
CalciMedica Inc (CALC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CalciMedica Inc (CALC) Valuation: PE, PB & Fair Value Analysis - TradingKey
CalciMedica, Inc. Revenue Breakdown – NASDAQ:CALC - TradingView
CalciMedica Inc (CALC) Income Statement - TradingKey
CalciMedica Inc (CALC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CALC|CalciMedica Inc|Price:0.658|Chg%:-0.001 - TradingKey
CalciMedica Inc. (CALC) Q1 2026 Earnings: Positive EPS Surprise Despite Absence of RevenueEarnings Momentum Score - dars.gov.et
CALC|CalciMedica Inc|Price:0.721|Chg%:-0.039 - TradingKey
CalcimedicaProspectus Covers Resale Of Up To 56,020,287 Shares Of Common StockSEC Filing - TradingView
CalciMedica (NASDAQ: CALC) files to register 56M shares from June 2026 PIPE - Stock Titan
CalciMedica Inc (CALC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Form DEF 14A ATAI Beckley Inc For: 23 July By Investing.com - Investing.com Canada
CalciMedica, Inc. SEC Filing (Jul 23, 2026) - Stock Titan
CalciMedica (NASDAQ: CALC) plans reverse split, 7.5M-share equity plan boost and warrant votes - Stock Titan
Price to earnings forward of CalciMedica, Inc. – NASDAQ:CALC - TradingView
Enterprise value to revenue forward of CalciMedica, Inc. – NASDAQ:CALC - TradingView
CalciMedica (CALC): CVI Investments and Heights Capital disclose 5.1% equity stake - Stock Titan
Enterprise value to EBITDA forward of CalciMedica, Inc. – NASDAQ:CALC - TradingView
CalciMedica (CALC) price target decreased by 24.39% to 10.54 - MSN
Form PRE 14A ATAI Beckley Inc For: 13 July By Investing.com - Investing.com Australia
CalciMedica (NASDAQ: CALC) plans reverse split and warrant votes - Stock Titan
CalciMedica Stock Short Interest Rises to 33.91% - Moomoo
CALC News | CALCIMEDICA INC (NASDAQ:CALC) - ChartMill
[Form 3] CalciMedica, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Alafi Capital Discloses Investment at CalciMedica with 17.1% Stake - TradingView
CalciMedica (CALC) gains 17.1% shareholder as Alafi Capital ups stake in $2.8M deal - Stock Titan
calcimedica inc glp-1 receptor agonists weight management diabetes treatments GLP-1 Receptor Agonists: antidiabetic and weight loss management drugs: A Complete Review - news36live
1.80%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):